Hikma Pharmaceuticals, founded in 1978 in Amman, Jordan, by Samih Darwazah, focuses on developing, manufacturing, and marketing a diverse range of pharmaceutical products. Initially concentrated on branded pharmaceuticals in the MENA region, the company expanded its operations in the early 1990s by acquiring a generic pharmaceutical business in the United States and establishing injectable pharmaceutical operations in Portugal. Hikma operates through three main segments: injectables, generics, and branded products, with the injectables segment being the primary revenue driver, supplying hospitals with generic injectable products. North America serves as the company's largest market, followed by the Middle East and North Africa, the United Kingdom, Europe, and other regions. Over the years, Hikma has grown significantly through both organic development and strategic acquisitions.
Roxane Laboratories, Inc., a specialty generics company, engages in the research, development, manufacture, marketing, sale, and distribution of generic pharmaceuticals in the United States. It markets a portfolio of 111 products in seven dosage forms, including immediate-release solids, nasal sprays, liquids, and sublingual tablet products. The company’s marketed products primarily include fluticasone, buprenorphine, methotrexate, prednisone, and calcium acetate.
Bedford Laboratories
Acquisition in 2014
Bedford Laboratories engages in the manufacture and distribution of generic injectables.
Egyptian Company for Pharmaceuticals & Chemical Industries
Acquisition in 2013
Egyptian Company for Pharmaceuticals & Chemical Industries manufacture pharmaceutical products. The company’s products include cephalosporin anti–infective medicines.
Promopharm SA is an industrial pharmaceutical company focused on the production, marketing, import, and export of a wide range of pharmaceutical products. This includes pharmaceuticals, parapharmaceuticals, dermopharmaceuticals, and cosmetics. The company's activities encompass both the development and distribution of these products, catering to various markets and consumer needs within the pharmaceutical and cosmetic sectors.
Unimark Remedies is a healthcare company based in Mumbai, India, established in 1982. The company specializes in the development and manufacture of generic medicines across various therapeutic areas, including respiratory, cardiovascular, anti-infective, and central nervous system disorders. In addition to pharmaceuticals, Unimark Remedies offers a range of healthcare products, which encompass diagnostics, medical devices, finished formulations, cosmeceuticals, animal healthcare products, and active pharmaceutical ingredients. With manufacturing facilities located in Ahmedabad, Vapi, and Khapoli, the company serves a global customer base, focusing on providing affordable healthcare solutions.
Jazeera Pharmaceuticals Industries is engages in the research, development, manufacture, and marketing of pharmaceutical products. It provides pharmaceutical products in tablet, syrup, and cream forms for applications in musculoskeletal, anti-infective, cardiovascular, CNS, respiratory, dermatology, alimentary, and genito-urinary therapeutic areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.